Effects of a Biotite-Derived Sulfated Ionic Aqueous Mineral Solution on Urinary Toxic-Metal Excretion and Essential Mineral Handling: A Controlled Pilot Study

Background. Toxic metals and essential minerals share transport, binding, and elimination pathways, so toxic-metal handling depends partly on mineral status. Interventions supplying a broad spectrum of minerals may therefore alter urinary toxic-metal excretion. Methods. Prospective, open-label, controlled pilot study. Experimental participants — a clinic population under treatment for chronic post-viral and post-vaccination illness — treated all drinking water with a biotite-derived sulfated ionic mineral solution at 5 mL per gallon and, as tolerated, added a concentrated oral dose of 1 mL per 20 pounds of body weight twice daily; healthy comparators received no intervention. Of 42 enrolled, 30 contributed paired specimens (20 experimental, 10 comparator) after withdrawals and the exclusion of six participants above the protocol age limit of 70 years. Urine panels covering 38 elements were obtained at baseline and follow-up (median interval 54 days, IQR 47–88). The protocol’s primary outcome was change in urinary toxic element levels; we compared changes from baseline between arms using the Mann–Whitney U test without multiplicity correction. A post hoc composite counted how many of six toxic metals — aluminum, arsenic, cadmium, lead, mercury, thallium — rose more than 15% from baseline; the threshold was fixed before that analysis and afterward a robustness check varied the threshold from 0 to 50% increases. Results. The protocol’s primary outcome — element-level change across the panel — was null: of the 38 elements measured, 29 had sufficient paired data for testing, and two reached nominal significance, aluminum (p = 0.024) and selenium (p = 0.018), against approximately 1.45 expected by chance; neither survives correction for multiplicity. The post hoc composite was not null. Experimental participants increased excretion across more toxic metals than comparators: a median of 3.0 of six versus 1.5 (p = 0.023, and p = 0.007–0.032 at every threshold from 0 to 50%). At least two metals rose in 95.0% versus 50.0% (p = 0.009). Applying the same threshold to six essential minerals, the arms did not differ (median 2.0 versus 2.0, p = 0.82). At post-study interview, eight of the 29 participants allocated to the experimental arm (27.6%) reported adverse effects: three were moderate to severe and required dose reduction or interruption; all resolved with adjustment, and none was serious. Five (17.2%) reported subjective improvement, and two more asked to continue treatment without describing a specific change; comparators were not interviewed. Conclusions. A biotite-derived sulfated ionic mineral complex was associated with increases in urinary excretion of more toxic metals than in contemporaneous comparators, while the number of essential minerals with increased excretion did not differ between arms. The direct within-person contrast favors selectivity for toxic elements by 15.8 percentage points (95% CI −10.3 to +41.5), an estimate this pilot is too small to resolve. The cause and mechanism of this change are uncertain, and urinary excretion alone cannot establish that body burden fell.